We are live on ! Find out more
ABUS icon

Arbutus Biopharma

122 hedge funds and large institutions have $189M invested in Arbutus Biopharma in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

327% more call options, than puts

Call options by funds: $5.24M | Put options by funds: $1.23M

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

50% more capital invested

Capital invested by funds: $126M → $189M (+$62.9M)

16% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 32

7% more funds holding

Funds holding: 114122 (+8)

3.79% more ownership

Funds ownership: 34.65%38.44% (+3.8%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
122
Holders Change
+8
Holders Change %
+7.02%
% of All Funds
1.94%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
20
Increased
37
Reduced
32
Closed
11
Calls
$5.24M
Puts
$1.23M
Net Calls
+$4.01M
Net Calls Change
+$2.04M
Name Holding Trade Value Shares
Change
Change in
Stake
Balyasny Asset Management
126
Balyasny Asset Management
Illinois
-$34.1K -14,633 Closed
Squarepoint
127
Squarepoint
New York
-$31.8K -13,650 Closed
DTL
128
Dynamic Technology Lab
Singapore
-$32K -13,630 Closed
AGM
129
Alpine Global Management
New York
-$24K -10,198 Closed
Zurich Cantonal Bank
130
Zurich Cantonal Bank
Switzerland
-$14.4K -6,178 Closed
CS
131
Credit Suisse
Switzerland
-$2.57K -1,102 Closed
Allspring Global Investments
132
Allspring Global Investments
North Carolina
-$2.33K -1,000 Closed